News
India annuls patent of Novartis' heart disease drug Vymada
The patent officer cited lack of novelty, insufficient inventive step, and inadequate disclosure of advantages in the patent application as reasons
Sep 16, 2025
This Site is Intended for Healthcare Professionals Only